Dr. Matthew Pabis, M.D

NPI: 1376981589
Total Payments
$158,268
2024 Payments
$61,291
Companies
65
Transactions
1,106
Medicare Patients
300
Medicare Billing
$65,910

Payment Breakdown by Category

Other$106,010 (67.0%)
Food & Beverage$27,037 (17.1%)
Consulting$19,030 (12.0%)
Travel$6,114 (3.9%)
Education$77.29 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $106,010 59 67.0%
Food and Beverage $27,037 1,015 17.1%
Consulting Fee $19,030 6 12.0%
Travel and Lodging $6,114 15 3.9%
Education $77.29 11 0.0%

Top Paying Companies

Company Total Records Latest Year
Alkermes, Inc. $101,161 203 $0 (2024)
Gilead Sciences, Inc. $20,999 205 $0 (2024)
Axsome Therapeutics, Inc. $19,054 26 $0 (2024)
ABBVIE INC. $2,383 102 $0 (2024)
Otsuka Pharmaceutical Development & Commercialization, Inc. $2,280 1 $0 (2024)
ViiV Healthcare Company $1,453 55 $0 (2024)
Lundbeck LLC $1,245 67 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $949.62 60 $0 (2024)
Otsuka America Pharmaceutical, Inc. $899.79 36 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $728.66 42 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $61,291 222 Alkermes, Inc. ($30,388)
2023 $23,500 192 Gilead Sciences, Inc. ($11,068)
2022 $32,480 221 Alkermes, Inc. ($28,594)
2021 $34,127 183 Alkermes, Inc. ($31,451)
2020 $976.38 52 Gilead Sciences, Inc. ($257.38)
2019 $2,903 98 Gilead Sciences, Inc. ($741.49)
2018 $1,888 66 Alkermes, Inc. ($601.20)
2017 $1,103 72 Collegium Pharmaceutical, Inc. ($188.30)

All Payment Transactions

1,106 individual payment records from CMS Open Payments — Page 1 of 45

Date Company Product Nature Form Amount Type
12/20/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $15.29 General
Category: CNS
12/18/2024 Otsuka Pharmaceutical Development & Commercialization, Inc. REJOYN (Device) Consulting Fee Cash or cash equivalent $2,280.00 General
Category: PSYCHIATRY
12/17/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $26.45 General
12/17/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $1.62 General
12/16/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $5.56 General
Category: PSYCHIATRY
12/11/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $22.73 General
Category: PSYCHIATRY
12/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $10.50 General
Category: Gastroenterology
12/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $8.42 General
Category: Gastroenterology
12/02/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $33.26 General
Category: Psychology/Psychiatric
11/28/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.15 General
Category: RESPIRATORY
11/26/2024 Alkermes, Inc. VIVITROL (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,370.00 General
Category: CNS
11/22/2024 Alkermes, Inc. VIVITROL (Drug) Food and Beverage In-kind items and services $34.04 General
Category: CNS
11/22/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $21.13 General
Category: NEUROSCIENCE
11/21/2024 ViiV Healthcare Company APRETUDE (Biological) Food and Beverage In-kind items and services $33.14 General
Category: HIV
11/21/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $24.17 General
Category: SCHIZOPHRENIA
11/20/2024 Alkermes, Inc. VIVITROL (Drug) Food and Beverage In-kind items and services $119.63 General
Category: CNS
11/18/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $34.33 General
Category: Psychiatry/Psychology
11/18/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $27.24 General
11/18/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $4.32 General
Category: PSYCHIATRY
11/18/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $1.10 General
11/11/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $35.42 General
Category: Psychiatry/Psychology
11/11/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $8.62 General
Category: NEUROSCIENCE
11/08/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $26.55 General
Category: VILOXAZINE HYDROCHLORIDE
11/07/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $3.23 General
11/04/2024 ViiV Healthcare Company APRETUDE (Biological) Food and Beverage In-kind items and services $34.43 General
Category: HIV

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 87 239 $47,791 $20,044
2022 2 65 176 $31,734 $15,516
2021 2 72 182 $31,459 $16,549
2020 3 76 203 $32,825 $13,801
Total Patients
300
Total Services
800
Medicare Billing
$65,910
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 55 174 $33,136 $13,178 39.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 32 65 $14,655 $6,866 46.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 40 132 $22,507 $10,428 46.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 25 44 $9,227 $5,088 55.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 43 134 $22,200 $11,044 49.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 29 48 $9,259 $5,505 59.5%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 41 132 $21,175 $8,626 40.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 22 42 $7,720 $3,936 51.0%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 13 29 $3,930 $1,239 31.5%

About Dr. Matthew Pabis, M.D

Dr. Matthew Pabis, M.D is a Family Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2013. The National Provider Identifier (NPI) number assigned to this provider is 1376981589.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Pabis, M.D has received a total of $158,268 in payments from pharmaceutical and medical device companies, with $61,291 received in 2024. These payments were reported across 1,106 transactions from 65 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($106,010).

As a Medicare-enrolled provider, Pabis has provided services to 300 Medicare beneficiaries, totaling 800 services with total Medicare billing of $65,910. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location New York, NY
  • Active Since 06/10/2013
  • Last Updated 01/09/2018
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1376981589

Products in Payments

  • VIVITROL (Drug) $89,029
  • Auvelity (Drug) $19,054
  • Epclusa (Drug) $11,909
  • Vivitrol (Drug) $10,451
  • REJOYN (Device) $2,280
  • VRAYLAR (Drug) $1,237
  • REXULTI (Drug) $1,162
  • ARISTADA (Drug) $892.53
  • APRETUDE (Biological) $762.33
  • CAPLYTA (Drug) $723.10
  • DOVATO (Drug) $690.32
  • Otezla (Drug) $580.65
  • ABILIFY MAINTENA (Drug) $566.47
  • Zubsolv (Drug) $532.84
  • TRINTELLIX (Drug) $522.88
  • RELISTOR (Drug) $519.06
  • UBRELVY (Drug) $381.98
  • Aristada 441 mg (Drug) $360.92
  • MAVYRET (Drug) $331.10
  • INVEGA SUSTENNA (Drug) $309.13

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in New York